Dual-Phase ADC Modelling of Breast Masses in Diffusion-Weighted Imaging: Comparison with Histopathologic Findings
PDF
Cite
Share
Request
Original Article
P: 85-92
April 2018

Dual-Phase ADC Modelling of Breast Masses in Diffusion-Weighted Imaging: Comparison with Histopathologic Findings

Eur J Breast Health 2018;14(2):85-92
1. Department of Biomedical Engineering, Yeditepe University, İstanbul, Turkey
2. Institute of Diagnostic and Interventional Radiology, Oberlausitz-Kliniken gGmbH, Bautzen, Germany
3. Department of Radiology, Marmara University School of Medicine, İstanbul, Turkey
4. Department of Radiology, Acıbadem Altunizade Hospital, İstanbul, Turkey
No information available.
No information available
Received Date: 18.10.2017
Accepted Date: 01.12.2017
PDF
Cite
Share
Request

ABSTRACT

Objective:

To investigate the diagnostic value of dual-phase apparent diffusion coefficient (ADC) compared to traditional ADC values in quantitative diffusion-weighted imaging (DWI) for differentiating between benign and malignant breast masses.

Materials and Methods:

Diffusion-weighted images of pathologically confirmed 88 benign and 85 malignant lesions acquired using a 3.0T MR scanner were analyzed. Small region-of-interests focusing on the highest signal intensity of lesions were used. Lesion ADC estimates were obtained separately from all b-value images (ADC; b=50, 400 and 800s/mm2), lower b-value images (ADClow; b=50 and 400s/mm2) and higher b-value images (ADChigh; b=400 and 800s/mm2). A set of dual-phase ADC (dpADC) models were constructed using ADClow, ADChigh and a perfusion influence factor ranging from 0 to 1.

Results:

Strong positive correlation is observable between ADC and all dpADCs (ρ=0.80-1.00). Differences in ADC and dpADCs between the benign and the malignant lesions are all significant (p<0.05). In detecting malignancy, traditional lesion ADC provides a good performance (AUC=89.9%) however dpADC0.5 (dpADC with a factor of 0.5) accomplishes a better performance (AUC=90.8%). At optimal thresholds, ADC achieves 94.1% sensitivity, 72.7% specificity and 83.2% accuracy while dpADC0.5 leads to 92.9% sensitivity, 79.5% specificity and 86.1% accuracy.

Conclusion:

Dual-phase ADC modelling may improve the accuracy in breast cancer diagnosis using DWI. Further prospective studies are needed to justify its benefit in clinical setting.

Article is only available in PDF format. Show PDF
2024 ©️ Galenos Publishing House